Showing results (451-460 of 478) with videos related to

Sort By:
Pageof 48
Tropical Animal Health and Production|December 6, 2012
Molecular characterization and phylogenetic analysis of infectious bursal disease viruses isolated from chicken in South China in 2011Di Liu, Xiang-Bin Zhang, Zhuan-Qiang Yan, et al.
Frontiers in Immunology|May 8, 2023
Role of macrophages in pulmonary arterial hypertensionMeng-Qi Zhang, Chen-Chen Wang, Xiao-Bin Pang, et al.
Current Medical Science|March 13, 2023
LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGRXue-Mei Xie, Qiu-Li Cao, Yu-Jie Sun, et al.
Journal of Medicinal Chemistry|March 13, 2026
Chemical Space Navigation of Nitidine Leads to the Discovery of a Novel PD-L1 Degradation Agent by Targeting CSN5 for Enhanced Antitumor ImmunityQun Wang, Mengmeng Guo, Yujia Song, et al.
Experimental and Therapeutic Medicine|August 17, 2017
Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expressionMing-Wei Liu, Rong Liu, Hai-Ying Wu, et al.
The ISME Journal|May 7, 2026
Trait-based signatures associated with persistence and thermal benefit in a genomically decayed coral probioticMei Xie, Congjuan Xu, Nan Xiang, et al.
International Immunopharmacology|April 26, 2023
Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-κB pathway in a triple transgenic mouse modelXin-Mei Xie, Jiao-Jiao Hao, Jun-Zhuo Shi, et al.
BMC Cancer|May 30, 2021
Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitisAiben Huang, Yang Xu, Xuelei Zang, et al.
The Journal of Clinical Investigation|February 2, 2026
Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1Mengting Xu, Xuwen Lin, Hanchi Xu, et al.
Journal of Thoracic Disease|November 13, 2025
Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysisAiben Huang, Mei Xie, Chongchong Wu, et al.
Pageof 48